History | Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapy | Guidance | NICE

History

Documents created during the development process.

Expected publication

Equality Impact Assessment (Guidance development) (PDF 244 KB)

Published:

16 May 2018

Final appraisal determination

Final appraisal determination
Final appraisal determination document (PDF 352 KB)

Published:

09 April 2018
Committee papers (PDF 4.05 MB)

Published:

09 April 2018
Public committee slides (PDF 707 KB)

Published:

09 April 2018

Draft guidance: 2

Draft guidance: 2
Appraisal consultation document (PDF 379 KB)

Published:

11 October 2017
Committee papers (PDF 4.08 MB)

Published:

11 October 2017
Public committee slides (PDF 515 KB)

Published:

11 October 2017

Draft guidance

Draft guidance
Appraisal consultation document (PDF 563 KB)

Published:

03 August 2017
Committee papers (PDF 35.34 MB)

Published:

03 August 2017
Public committee slides (PDF 1.23 MB)

Published:

03 August 2017

Invitation to participate

Final scope (PDF 239 KB)

Published:

15 December 2016
Final matrix (PDF 297 KB)

Published:

15 December 2016
NICE's response to comments on the draft scope and provisional matrix (PDF 315 KB)

Published:

15 December 2016
Equality impact assessment (Scoping) (PDF 171 KB)

Published:

15 December 2016